Skip to main content
Livermore
Livermore
ZHEN

Fifth Third Bancorp

SEC CIK
0000035527
Latest filing
Aug 5, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
30,636
Value
$1.04M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TEVA by Fifth Third Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202630,636$1.04M<0.1%−232−0.8%ReducedHolders
Q1 202630,868$929.7K<0.1%−932−2.9%ReducedHolders
Q4 202531,800$992.5K<0.1%+2,155+7.3%AddedHolders
Q3 202529,645$598.8K<0.1%−3,160−9.6%ReducedHolders
Q2 202532,805$549.8K<0.1%+10,820+49.2%AddedHolders
Q1 202521,985$337.9K<0.1%+3,265+17.4%AddedHolders
Q4 202418,720$412.6K<0.1%+18,444+6,682.6%AddedHolders
Q3 2024276$4.97K<0.1%00.0%UnchangedHolders
Q2 2024276$4.49K<0.1%+51+22.7%AddedHolders
Q1 2024225$3.17K<0.1%00.0%UnchangedHolders
Q4 2023225$2.35K<0.1%−71−24.0%ReducedHolders
Q3 2023296$3.02K<0.1%−132−30.8%ReducedHolders
Q2 2023428$3.22K<0.1%−58−11.9%ReducedHolders
Q1 2023486$4.30K<0.1%+402+478.6%AddedHolders
Q4 202284$766<0.1%−1,019−92.4%ReducedHolders
Q3 20221,103$9.00K<0.1%+58+5.6%AddedHolders
Q2 20221,045$8.00K<0.1%−80−7.1%ReducedHolders
Q1 20221,125$11.0K<0.1%+80+7.7%AddedHolders
Q4 20211,045$8.00K<0.1%−545−34.3%ReducedHolders
Q3 20211,590$15.0K<0.1%−55,755−97.2%ReducedHolders
Q2 202157,345$568.0K<0.1%+2,492+4.5%AddedHolders
Q1 202154,853$633.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.